Non-inferiority trials

  • Shengping Yang The Department of Pathology (Yang) and Internal Medicine (Berdine) at Texas Tech University Health Sciences Center, Lubbock, TX
  • Gilbert Berdine The Department of Internal Medicine at Texas Tech University Health Sciences Center, Lubbock, TX
DOI: https://doi.org/10.12746/swrccc.v5i21.424

Downloads

Download data is not yet available.

References

Pui CH, Evans WE. A 50-year journey to cure childhood

acute lymphoblastic leukemia. Semin Hematol 2013 Jul;

(3):185–196.

Food and Drug Administration. Non-inferiority clinical

trials

to establish effectiveness: guidance for industry 2016.

Accessed Oct. 6, 2017.

Kaul S, Diamond GA. Good enough: A primer on the analysis

and interpretation of noninferiority trials. Annals Int Med

;145:62–69.

Hahn S. Understanding noninferiority trials. Korean J Pediatr

;55(11):403–7.

Snapinn SM. Noninferiority trials. Curr Control Trials Cardiovasc

Med 2000;1(1):19–21.

Published
2017-10-16
How to Cite
Yang, S., & Berdine, G. (2017). Non-inferiority trials. The Southwest Respiratory and Critical Care Chronicles, 5(21), 50-52. https://doi.org/10.12746/swrccc.v5i21.424
Issue
Vol 5 No 21 (2017): The Southwest Respiratory and Critical Care Chronicles
Section
Statistics Column
Crossref
Scopus
Google Scholar
Europe PMC